Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden.
4 reports, 3 independent
Updated Aug 7
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Texas Tech University led the development of the SchistoShield vaccine for schistosomiasis, conducting trials in African locations.Sub-event
Vaccine trials are underway in Africa, coinciding with WHO estimates of disease burden.1 source
Keep exploring
The entities involved
-
Africa
continent
-
World Health Organization
United Nations agency concerned with international public health
Related events
- During a ministerial forum in Addis Ababa, President Ruto called on the African continent to enhance its capacity for vaccine manufacturing.
- The FDA aligned vaccine formulas with global health recommendations provided by the World Health Organization.
- The African Alliance for Allergy and Clinical Immunology addressed health burdens across the continent.
- International partners began assisting Africa with vaccine procurement and delivery systems on September 1st.